USE OF AZAPHILONE COMPOUNDS FOR THE MODULATION OF THE ACTIVITY OF A NUCLEAR HORMONE RECEPTOR
申请人:LIU Ta-Wei D.
公开号:US20100256227A1
公开(公告)日:2010-10-07
The present invention concerns the uses of an azaphilone compound of formula (I):
formula (I):
or a pharmaceutically acceptable derivative thereof as described in the specification for modulation of the activity of a nuclear hormone receptor and for prevention and/or treatment of a disease or disorder related to nuclear hormone receptor activity.